Work

Lenalidomide and Prednisone in Low and Intermediate-1 IPSS Risk, Non-Del(5q) Patients With Myelodysplastic Syndromes: Phase 2 Clinical Trial

Year: 2019

Type: article

Study design: Clinical Trial

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2018.12.014

Authors: Rami S. Komrokji, Najla H. Al Ali, Eric Padron, Christopher Cogle, Sara Tinsley, David Sallman, Jeffrey E. Lancet, Alan F. Lis

Institutions: Moffitt Cancer Center, University of Florida Health, University of Florida, UF Health Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Celgene

OpenAlex ID: W2907930551

FWCI: 0.706

Cites: 13

Cited by: 5

Related to: 10